<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33602014</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>sup1</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Better understanding the neurobiology of primary lateral sclerosis.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>46</EndPage><MedlinePgn>35-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2020.1837175</ELocationID><Abstract><AbstractText>Primary lateral sclerosis (PLS) is a rare neurodegenerative disease characterized by progressive degeneration of upper motor neurons (UMNs). Recent studies shed new light onto the cellular events that are particularly important for UMN maintenance including intracellular trafficking, mitochondrial energy homeostasis and lipid metabolism. This review summarizes these advances including the role of Alsin as a gene linked to atypical forms of juvenile PLS, and discusses wider aspects of cellular pathology that have been observed in adult forms of PLS. The review further discusses the prospects of new transgenic upper motor neuron reporter mice, human stem cell-derived UMN cultures, cerebral organoids and non-human primates as future model systems to better understand and ultimately treat PLS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ozdinler</LastName><ForeName>P Hande</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gautam</LastName><ForeName>Mukesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gozutok</LastName><ForeName>Oge</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konrad</LastName><ForeName>Csaba</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Weill Cornell Medicine, Feil Family Brain and Mind Research Institute, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manfredi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Weill Cornell Medicine, Feil Family Brain and Mind Research Institute, New York, NY USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Area Gomez</LastName><ForeName>Estela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitsumoto</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eleanor and Lou Gehrig ALS Center, Columbia University Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erb</LastName><ForeName>Marcella L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>School of Medicine Light Microscopy Core, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Biological Sciences, University of California San Diego, La Jolla, CA, 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haase</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Biological Sciences, University of California San Diego, La Jolla, CA, 92093, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Systems Neuroscience, Marseille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 NS047101</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG061708</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS093872</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020662">Guanine Nucleotide Exchange Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020662" MajorTopicYN="N">Guanine Nucleotide Exchange Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS2</Keyword><Keyword MajorTopicYN="N">Alsin</Keyword><Keyword MajorTopicYN="N">Betz cell</Keyword><Keyword MajorTopicYN="N">Golgi apparatus</Keyword><Keyword MajorTopicYN="N">bioenergetics</Keyword><Keyword MajorTopicYN="N">corticospinal motor neuron</Keyword><Keyword MajorTopicYN="N">endosomes</Keyword><Keyword MajorTopicYN="N">membrane lipids</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">primary lateral sclerosis</Keyword><Keyword MajorTopicYN="N">upper motor neuron</Keyword></KeywordList><CoiStatement>Declaration of interest. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>19</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33602014</ArticleId><ArticleId IdType="mid">NIHMS1683560</ArticleId><ArticleId IdType="pmc">PMC8016556</ArticleId><ArticleId IdType="doi">10.1080/21678421.2020.1837175</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Erb WH. Ueber einen wenig bekanten spinalen Symptomenkomplex. About a little-known spinal symptom complex. Berliner Klinische Wochenschrift 1875;26:357&#x2013;9.</Citation></Reference><Reference><Citation>Stark FM, Moersch FP. Primary lateral sclerosis. A distinct clinical entity. J Nerv Mental Dis. 1945;102:332&#x2013;7.</Citation></Reference><Reference><Citation>Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992;115: 495&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">1606479</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology 2006;66:647&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Nagy PL, Gennings C, Murphy J, Andrews H, Goetz R, et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet. 2015;1:e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4821084</ArticleId><ArticleId IdType="pubmed">27066542</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazulla J, Ferrer I, Izquierdo-Alvarez S, Alvarez S, Sanchez-Alcudia R, Bestue-Cardiel M, et al. Hereditary primary lateral sclerosis and progressive nonfluent aphasia. J Neurol. 2019;266:1079&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">30834979</ArticleId></ArticleIdList></Reference><Reference><Citation>Statland JM, Barohn RJ, Dimachkie MM, Floeter MK, Mitsumoto H. Primary lateral sclerosis. Neurol Clin. 2015;33:749&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4628724</ArticleId><ArticleId IdType="pubmed">26515619</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier CN, Murphy A, Loci L, Mitsumoto H, Lomen-Hoerth C, Kisanuki Y, et al. Primary lateral sclerosis and early upper motor neuron disease: characteristics of a cross-sectional population. J Clin Neuromuscul Dis. 2016;17:99&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4770823</ArticleId><ArticleId IdType="pubmed">26905909</ArticleId></ArticleIdList></Reference><Reference><Citation>Charcot J-M, Joffroy A. Deux cas d&#x2019;atrophie musculaire progressive avec l&#xe9;sion de la substance grise et des faisceaux de la moelle &#xe9;pini&#xe8;re. Arch Physiol 1869;2:354&#x2013;67. 629&#x2013;49; 744&#x2013;60.</Citation></Reference><Reference><Citation>Charcot JM. Scl&#xe9;rose des cordons lat&#xe9;raux. Gazette h&#xe9;bdomadaire 1865;7:109&#x2013;110.</Citation></Reference><Reference><Citation>Charcot JM. Le&#xe7;ons sur les Maladies du Syst&#xe8;me Nerveux faites &#xe0; la Salp&#xea;tri&#xe8;re. Paris V: Aux Bureaux du Progr&#xe8;s M&#xe9;dical. Adrien Delahaye. Libraires-Editeurs 1877.</Citation></Reference><Reference><Citation>Wais V, Rosenbohm A, Petri S, Kollewe K, Hermann A, Storch A, et al. The concept and diagnostic criteria of primary lateral sclerosis. Acta Neurol Scand. 2017;136:204&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">27858953</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, et al. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum. J Neurol. 2018;265:1819&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">29868980</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, et al. Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry. 2020;91:373&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147236</ArticleId><ArticleId IdType="pubmed">32029539</ArticleId></ArticleIdList></Reference><Reference><Citation>Barohn RJ, Fink JK, Heiman-Patterson T, Huey ED, Murphy J, Statland JM, et al. The clinical spectrum of primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. To appear.</Citation><ArticleIdList><ArticleId IdType="pubmed">33602013</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmore M, Elman L, Babu S, Andres P, Floeter MK. Measuring PLS disease progression. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. To appear.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7899091</ArticleId><ArticleId IdType="pubmed">33602016</ArticleId></ArticleIdList></Reference><Reference><Citation>Silani V, Corcia P, Harms MB, Rouleau G, Siddique T, Ticozzi N. Genetics of primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. To appear.</Citation><ArticleIdList><ArticleId IdType="pubmed">33602012</ArticleId></ArticleIdList></Reference><Reference><Citation>Pioro E, Turner MR, Bede P. Neuroimaging in primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. To appear.</Citation><ArticleIdList><ArticleId IdType="pubmed">33602015</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Kiernan MC, Pullman SL, Rezania K, Simmons Z. Neurophysiological features of primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. To appear.</Citation><ArticleIdList><ArticleId IdType="pubmed">33602011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Briemberg H. TDP-43 pathology in primary lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. July 11:1&#x2013;7. Crossref</Citation></Reference><Reference><Citation>Floeter MK, Warden D, Lange D, Wymer J, Paganoni S, Mitsumoto H. Clinical care and therapeutic trials in PLS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2020. To appear.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7899088</ArticleId><ArticleId IdType="pubmed">33602017</ArticleId></ArticleIdList></Reference><Reference><Citation>Purves D Neuroscience. 3d ed. Sunderland, MA: Sinauer Associates; 2007.</Citation></Reference><Reference><Citation>The Thalamus and Cerebral Cortex (Integrative Systems) Part 1: What-when-how. In depth tutorials and information; Available at: http://what-when-how.com/neuroscience/the-thalamus-and-cerebral-cortex-integrative-systems-part-1/.</Citation></Reference><Reference><Citation>Lemon RN. Descending pathways in motor control. Annu Rev Neurosci. 2008;31:195&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">18558853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemon RN, Kirkwood PA, Maier MA, Nakajima K, Nathan P. Direct and indirect pathways for corticospinal control of upper limb motoneurons in the primate. Prog Brain Res. 2004;143:263&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">14653171</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, Jara JH, Kocak N, Rylaarsdam LE, Kim KD, Bigio EH, et al. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathol. 2019;137:47&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Jara JH, Lagrimas AK, Pytel P, Roos RP, Mesulam MM, et al. Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS. Sci Rep. 2017;7:41765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5292972</ArticleId><ArticleId IdType="pubmed">28165465</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd GM. Diversity and complexity in the pyramidal tract projectome. Nat Rev Neurosci. 2014;15:63.</Citation><ArticleIdList><ArticleId IdType="pubmed">24301062</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris KD, Shepherd GM. The neocortical circuit: themes and variations. Nat Neurosci. 2015;18:170&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4889215</ArticleId><ArticleId IdType="pubmed">25622573</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamawaki N, Shepherd GM. Synaptic circuit organization of motor corticothalamic neurons. J Neurosci. 2015;35:2293&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4315846</ArticleId><ArticleId IdType="pubmed">25653383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooks BM, Mao T, Gutnisky DA, Yamawaki N, Svoboda K, Shepherd GM. Organization of cortical and thalamic input to pyramidal neurons in mouse motor cortex. J Neurosci. 2013;33:748&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710148</ArticleId><ArticleId IdType="pubmed">23303952</ArticleId></ArticleIdList></Reference><Reference><Citation>Suter BA, Yamawaki N, Borges K, Li X, Kiritani T, Hooks BM, et al. Neurophotonics applications to motor cortex research. Neurophoton. 2014;1:011008.</Citation></Reference><Reference><Citation>Turner M, Cosgrove J, Jamieson S, Chowdhury FU. Teaching neuroimages: hypometabolism of the primary motor cortex in primary lateral sclerosis: the stripe sign. Neurology 2016;86:1464.</Citation><ArticleIdList><ArticleId IdType="pubmed">27163663</ArticleId></ArticleIdList></Reference><Reference><Citation>Suter BA, Migliore M, Shepherd GM. Intrinsic electrophysiology of mouse corticospinal neurons: a class-specific triad of spike-related properties. Cereb Cortex. 2013;23:1965&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3698370</ArticleId><ArticleId IdType="pubmed">22761308</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Sheets PL, Nigro MJ, Peric M, Brooks C, Heller DB, et al. The electrophysiological determinants of corticospinal motor neuron vulnerability in ALS. Front Mol Neurosci 2020;13:e00073.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7248374</ArticleId><ArticleId IdType="pubmed">32508590</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Kiernan MC. Transcranial magnetic stimulation for the assessment of neurodegenerative disease. Neurotherapeutics. 2017;14:91&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233629</ArticleId><ArticleId IdType="pubmed">27830492</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S, Koch G, Hillis AE, Huynh W, Ward NS, Vucic S, et al. Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke. J Neurol Neurosurg Psychiatry. 2019;90:47&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">29866706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Melhem ER. Amyotrophic lateral sclerosis and primary lateral sclerosis: the role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers. Ann NY Acad Sci. 2005;1064:61&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">16394148</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Klenowski PM, Lee JD, Drieberg-Thompson JR, Bartlett SE, Ngo ST, et al. Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis. Sci Rep. 2016;6:37968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5126629</ArticleId><ArticleId IdType="pubmed">27897242</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Villa SR, Khan NA, Bohn MC, Ozdinler PH. AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS. Neurobiol Dis. 2012;47:174&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049520</ArticleId><ArticleId IdType="pubmed">22521461</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Genc B, Cox GA, Bohn MC, Roos RP, Macklis JD, et al. Corticospinal motor neurons are susceptible to increased ER stress and display profound degeneration in the absence of UCHL1 function. Cereb Cortex. 2015;25:4259&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626833</ArticleId><ArticleId IdType="pubmed">25596590</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, Jara JH, Sekerkova G, Yasvoina MV, Martina M, Ozdinler PH. Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms. Hum Mol Genet. 2016;25:1074&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4764190</ArticleId><ArticleId IdType="pubmed">26755825</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Alshikho MJ, Zurcher NR, Cernasov P, Babu S, Loggia ML, et al. Imaging of glia activation in people with primary lateral sclerosis. Neuroimage Clin. 2018;17:347&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5681341</ArticleId><ArticleId IdType="pubmed">29159046</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemon R Recent advances in our understanding of the primate corticospinal system. F1000Res. 2019;8:274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6415323</ArticleId><ArticleId IdType="pubmed">30906528</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Ozdinler PH. Moving forward in clinical trials for ALS: motor neurons lead the way please. Drug Discovery Today. 2014;19:441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000750</ArticleId><ArticleId IdType="pubmed">24171950</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Gozutok O, Ozdinler PH. Complexity of generating mouse models to study the upper motor neurons: let us shift focus from mice to neurons. Int J Mol Sci. 2019;20:3848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6720674</ArticleId><ArticleId IdType="pubmed">31394733</ArticleId></ArticleIdList></Reference><Reference><Citation>Otomo A, Hadano S, Okada T, Mizumura H, Kunita R, Nishijima H, et al. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics. Hum Mol Genet. 2003;12:1671&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">12837691</ArticleId></ArticleIdList></Reference><Reference><Citation>Topp JD, Carney DS, Horazdovsky BF. Biochemical characterization of Alsin, a Rab5 and Rac1 guanine nucleotide exchange factor. Methods Enzymol. 2005;403:261&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">16473593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Benn SC, Kakuta S, Otomo A, Sudo K, Kunita R, et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum Mol Genet. 2006;15:233&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">16321985</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. 2001;29:160&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11586297</ArticleId></ArticleIdList></Reference><Reference><Citation>Eymard-Pierre E, Lesca G, Dollet S, Santorelli FM, di Capua M, Bertini E, et al. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet. 2002;71:518&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC379189</ArticleId><ArticleId IdType="pubmed">12145748</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone M, Trabacca A, Panzeri E, Losito L, Citterio A, Bassi MT. KIF5A and ALS2 variants in a family with hereditary spastic paraplegia and amyotrophic lateral sclerosis. Front Neurol 2018;9:1078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6293196</ArticleId><ArticleId IdType="pubmed">30581417</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai H, Lin X, Xie C, Laird FM, Lai C, Wen H, et al. Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress. J Neurosci. 2005;25:7567&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2364727</ArticleId><ArticleId IdType="pubmed">16107644</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Zhai H, Fu R, Shi Y, Gorrie GH, Yang Y, et al. Distal axonopathy in an alsin-deficient mouse model. Hum Mol Genet. 2007;16:2911&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">17855450</ArticleId></ArticleIdList></Reference><Reference><Citation>Devon RS, Orban PC, Gerrow K, Barbieri MA, Schwab C, Cao LP, et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc Natl Acad Sci USA. 2006;103:9595&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1480452</ArticleId><ArticleId IdType="pubmed">16769894</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Miller TM, McAlonis-Downes M, Chun SJ, Cleveland DW. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice. Ann Neurol. 2006;60:95&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">16802286</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasvoina MV, Genc B, Jara JH, Sheets PL, Quinlan KA, Milosevic A, et al. eGFP expression under UCHL1 promoter genetically labels corticospinal motor neurons and a subpopulation of degeneration-resistant spinal motor neurons in an ALS mouse model. J Neurosci. 2013;33:7890&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3963467</ArticleId><ArticleId IdType="pubmed">23637180</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase G, Rabouille C. Golgi fragmentation in ALS motor neurons. New mechanisms targeting microtubules, tethers, and transport vesicles. Front Neurosci. 2015;9:448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4672084</ArticleId><ArticleId IdType="pubmed">26696811</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabouille C, Haase G. Editorial: golgi pathology in neurodegenerative diseases. Front Neurosci. 2015;9:489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4701922</ArticleId><ArticleId IdType="pubmed">26778948</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquier A, Buhler E, Sch&#xe4;fer MK, Bohl D, Blanchard S, Beclin C, et al. Alsin/Rac1 signaling controls survival and growth of spinal motoneurons. Ann Neurol. 2006;60:105&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">16802292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C, Xie C, Shim H, Chandran J, Howell BW, Cai H. Regulation of endosomal motility and degradation by amyotrophic lateral sclerosis 2/alsin. Mol Brain. 2009;2:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2724476</ArticleId><ArticleId IdType="pubmed">19630956</ArticleId></ArticleIdList></Reference><Reference><Citation>Topp JD, Gray NW, Gerard RD, Horazdovsky BF. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J Biol Chem. 2004;279:24612&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">15033976</ArticleId></ArticleIdList></Reference><Reference><Citation>Otomo A, Kunita R, Suzuki-Utsunomiya K, Mizumura H, Onoe K, Osuga H, et al. ALS2/alsin deficiency in neurons leads to mild defects in macropinocytosis and axonal growth. Biochem Biophys Res Commun. 2008;370:87&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">18358238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Otomo A, Kunita R, Suzuki-Utsunomiya K, Akatsuka A, Koike M, et al. Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking. PLoS One. 2010;5:e9805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2842444</ArticleId><ArticleId IdType="pubmed">20339559</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu F, Spannl S, Ferguson C, Hyman AA, Parton RG, Zerial M. Rab5 and Alsin regulate stress-activated cytoprotective signaling on mitochondria. eLife. 2018;7:e32282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5847334</ArticleId><ArticleId IdType="pubmed">29469808</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquier A, Bellouze S, Blanchard S, Bohl D, Haase G. Astrocytic protection of spinal motor neurons but not cortical neurons against loss of Als2/alsin function. Hum Mol Genet. 2009;18:2127&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">19304783</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J, Cortez C, Gan WB, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet. 2014;23:1413&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Vande Velde C, Israelson A, Xie J, Bailey AO, Dong MQ, et al. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci USA. 2010;107:21146&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000256</ArticleId><ArticleId IdType="pubmed">21078990</ArticleId></ArticleIdList></Reference><Reference><Citation>Millecamps S, Gentil BJ, Gros-Louis F, Rouleau G, Julien JP. Alsin is partially associated with centrosome in human cells. Biochim Biophys Acta. 2005;1745:84&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">16085057</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo C, Morbelli S, Girtler N, Mandich P, Mancardi GL, Caponnetto C, et al. Bilateral motor and premotor cortex hypometabolism in a case of Mills syndrome. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:414&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25967545</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills CK. A case of unilateral progressive ascending paralysis, probably representing a new form of degenerative disease. J Nerv Ment Dis 1900;27:195&#x2013;200.</Citation></Reference><Reference><Citation>Gastaut JL, Bartolomei F. Mills&#x2019; syndrome: ascending (or descending) progressive hemiplegia: a hemiplegic form of primary lateral sclerosis? J Neurol Neurosurg Psychiatry. 1994;57:1280&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC485513</ArticleId><ArticleId IdType="pubmed">7931406</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach RL, Rao JS, Festoff BW, Reyes ET, Yanagihara R, Gajdusek DC. Collagenase activity in skin fibroblasts of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1986;72:49&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">3005515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S, Imai T, Tsumura M, Takahashi K, Jinnai K, Suzuki M, et al. Increased serum hyaluronic acid in amyotrophic lateral sclerosis: relation to its skin content. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:213&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464955</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukie T, Masaki H, Yoshida S, Fujikura M, Ono S. Decreased Amount of Collagen in The Skin of Amyotrophic Lateral Sclerosis in The Kii Peninsula of Japan. Acta Neurol Taiwan 2014;23:82&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26077179</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Zhang KY, Kariawasam R, Bax M, Fifita JA, Ooi L, et al. Evaluation of skin fibroblasts from amyotrophic lateral sclerosis patients for the rapid study of pathological features. Neurotox Res. 2015;28:138&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">26013250</ArticleId></ArticleIdList></Reference><Reference><Citation>Oketa Y, Higashida K, Fukasawa H, Tsukie T, Ono S. Abundant FUS-immunoreactive pathology in the skin of sporadic amyotrophic lateral sclerosis. Acta Neurol Scand. 2013;128:257&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">23448665</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T, Okeda Y, Yamano T, Ono S. An immunohistochemical study of ubiquitin in the skin of sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2010;298:52&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20850799</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, Mikami H, Watanabe T, Yamano T, Yamazaki T, Nomura M, et al. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta Neurol Scand 2010;122:367&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">20175762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk K, Gennings C, Hupf JC, Tadesse S, D&#x2019;Aurelio M, Kawamata H, et al. Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Ann Neurol. 2014;76:620&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4192005</ArticleId><ArticleId IdType="pubmed">25090982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollari E, Goldsteins G, Bart G, Koistinaho J, Giniatullin R. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front Cell Neurosci 2014;8:131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4026683</ArticleId><ArticleId IdType="pubmed">24860432</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, et al. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol Neurodegener. 2017;12:76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655870</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId></ArticleIdList></Reference><Reference><Citation>Borroni MV, Valles AS, Barrantes FJ. The lipid habitats of neurotransmitter receptors in brain. Biochim Biophys Acta. 2016;1858:2662&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">27424801</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingolfsson HI, Melo MN, van Eerden FJ, Arnarez C, Lopez CA, Wassenaar TA, et al. Lipid organization of the plasma membrane. J Am Chem Soc. 2014;136:14554&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25229711</ArticleId></ArticleIdList></Reference><Reference><Citation>Arima H, Omura T, Hayasaka T, Masaki N, Hanada M, Xu D, et al. Reductions of docosahexaenoic acid-containing phosphatidylcholine levels in the anterior horn of an ALS mouse model. Neuroscience 2015;297:127&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">25841322</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Croixmarie V, Priestman DA, Rosenbohm A, Dirrig-Grosch S, D&#x2019;Ambra E, et al. Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase. Hum Mol Genet. 2015;24:7390&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4664174</ArticleId><ArticleId IdType="pubmed">26483191</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Huebecker M, Blasco H, Keime C, Andres CR, Corcia P, et al. Inhibition of &#x3b2;-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis . Sci Rep. 2017;7:5235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5507914</ArticleId><ArticleId IdType="pubmed">28701774</ArticleId></ArticleIdList></Reference><Reference><Citation>Okumiya K, Sakamoto R, Ishimoto Y, Kimura Y, Fukutomi E, Ishikawa M, et al. Glucose intolerance associated with hypoxia in people living at high altitudes in the Tibetan highland. BMJ Open. 2016;6:e009728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4769430</ArticleId><ArticleId IdType="pubmed">26908520</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:133&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">30654671</ArticleId></ArticleIdList></Reference><Reference><Citation>Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR, et al. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther. 2012;23:382&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3327605</ArticleId><ArticleId IdType="pubmed">22201473</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo-Hernandez M, Tadokoro T, Navarro MR, Platoshyn O, Kobayashi Y, Marsala S, et al. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS. Nat Med. 2020;26:118&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">31873312</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, et al. Towards a transgenic model of Huntington&#x2019;s disease in a non-human primate. Nature 2008;453:921&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2652570</ArticleId><ArticleId IdType="pubmed">18488016</ArticleId></ArticleIdList></Reference><Reference><Citation>Cathomen T, Ehl S. Translating the genomic revolution &#x2013; targeted genome editing in primates. N Engl J Med. 2014;370:2342&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24918378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdinler PH, Silverman RB. Treatment of amyotrophic lateral sclerosis: lessons learned from many failures. ACS Med Chem Lett. 2014;5:1179&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4233364</ArticleId><ArticleId IdType="pubmed">25408825</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Fumagalli L, Prior R, Van Den Bosch L. Current advances and limitations in modeling ALS/FTD in a dish using induced pluripotent stem cells. Front Neurosci. 2017;11:671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5733489</ArticleId><ArticleId IdType="pubmed">29326542</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Kirwan P, Smith J, Robinson HP, Livesey FJ. Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci. 2012;15:477&#x2013;86, S1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3882590</ArticleId><ArticleId IdType="pubmed">22306606</ArticleId></ArticleIdList></Reference><Reference><Citation>Motono M, Ioroi Y, Ogura T, Takahashi J. WNT-C59, a small-molecule WNT inhibitor, efficiently induces anterior cortex that includes cortical motor neurons from human pluripotent stem cells. Stem Cells Transl Med. 2016;5:552&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4798742</ArticleId><ArticleId IdType="pubmed">26941358</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature 2013;501:373&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3817409</ArticleId><ArticleId IdType="pubmed">23995685</ArticleId></ArticleIdList></Reference><Reference><Citation>Camp JG, Badsha F, Florio M, Kanton S, Gerber T, Wilsch-Brauninger M, et al. Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc Natl Acad Sci USA. 2015;112:15672&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4697386</ArticleId><ArticleId IdType="pubmed">26644564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormel PR, Vieira de Sa R, van Bodegraven EJ, Karst H, Harschnitz O, Sneeboer MAM, et al. Microglia innately develop within cerebral organoids. Nat Commun. 2018;9:4167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6177485</ArticleId><ArticleId IdType="pubmed">30301888</ArticleId></ArticleIdList></Reference><Reference><Citation>Quadrato G, Nguyen T, Macosko EZ, Sherwood JL, Min Yang S, Berger DR, et al. Cell diversity and network dynamics in photosensitive human brain organoids. Nature 2017;545:48&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5659341</ArticleId><ArticleId IdType="pubmed">28445462</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>